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Abstract
Purpose:We report a rare case of CRB1gene mutation in two siblings (sisters) affected with the exact same
genetic mutation on both CRB1genes resulting in varying phenotypes.
Case Report: CRB1gene mutation in this case has resulted in causing varying degrees of Leber congenital
amaurosis (LCA) in both sisters with a more severe phenotype in the older sibling causing LCA-8 with
retinitis pigmentosa spectrum in both eyes and a milder phenotype causing LCA-8 with less severe rod
cone dystrophy in the younger sister.
Conclusion: In summary, the mechanisms of varying phenotypes resulting from CRB1 genetic mutation are
still not well understood. We concluded that the presence of different phenotypes associated with identical
genotypic mutation of a single gene in siblings or in a family is important especially when dealing with retinal
dystrophies.
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Mutations in CRB1gene are associated with several
types of autosomal recessive retinal dystrophies,
such as retinitis pigmentosa, Leber congenital
amaurosis (LCA),[1] and Coats-like vasculopathy.[1]
LCA is the most common genetically defined,
severe rod cone dystrophy causing pronounced
visual impairment. It has a very guarded prognosis
and usually progresses very rapidly but could be
even worse when associated with a complication
such as Coats-like vasculopathy.[1] LCA has been
associated with 18 different genetic mutations.[2]
CRB1gene mutation is responsible for causing LCA
defined as type 8.[2, 3] Our case report represents
two sisters affected by exactly identical CRB1gene
mutation but exhibiting varying phenotypes that
have not been reported previously for this disease
spectrum in siblings (sisters).
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CASE REPORT
We present two sisters affected by CRB1gene
mutation.
First Patient (Older Sister)
A 58-year-old female patient visited the retina clinic
in the North Devon District Hospital (NDDH), Barn-
staple, UK in April 2012. She had a long history of
poor vision and complained of further deterioration
of vision in both eyes; she was referred to the clinic
by her general practitioner (GP).
The patient had suffered from significant ocu-
lar problems since childhood. The condition pro-
gressed rapidly, and she was registered as blind
after a few years. She was previously diagnosed
with severe macular dystrophy in both eyes at
the Moorfields Eye Hospital, London. A differen-
tial diagnosis suggested a possibility of fundus
flavimaculatus, Sorsby’s dystrophy, and Best vitel-
liform macular dystrophy. The patient underwent
fluorescein angiography at the Moorfields Eye
Hospital which revealed profound atrophy of retinal
pigment epithelium (RPE) at the posterior pole in
both eyes along with widespread retinal edema
and microvascular changes. She also underwent
electrophysiological testing at that time, which
included electroretinogram (ERG) and electroocu-
logram (EOG). ERG and EOG were both performed
on an in-house manufactured electrophysiologi-
cal visual evoked potential machine called the
“Observe-reviewer” system at the Moorfields Eye
Hospital, UK. The EOG was reported to be abnor-
mal and showed no light rise in either eye. The
ERG was performed with gold foil recording elec-
trodes according to the international standards. It
showed very low scotopic and photopic responses
on both sides. Her rod ERG showed almost no
response and there were very small “a” and “b”
waveswhichweremarkedly delayed on both sides.
The single flash cone ERG response also had
a very small amplitude with significantly delayed
latency and the single flash cone ERG “b” wave
amplitude was recorded to be less than the half of
a normal response. In summary, her full-field ERG
was abnormal for rods and cones, both being very
reduced and delayed.
Her family history revealed unknown eye prob-
lems in her younger sister as well.
On examination in the clinic at NDDH, the
woman could count fingers using both eyes and
the vision did not improve with pinhole examina-
tion. She had an unremarkable anterior segment
examination with clear lenses. Pupil reactions were
sluggish on both sides. Intraocular pressure (IOP)
was in the normal range in both eyes. Retinal
examination revealed retinal pigmentation with
some bony spicules mainly affecting her macular
areas along with paravenous pigmentation seen
in some areas of both eyes as observed from
her fundus photos [Figures 1 and 2]. Macular
examination did not show signs of macular edema.
She had mildly pale optic discs bilaterally. Optical
coherence tomography (OCT) scan was performed
with Topcon 3D-OCT 2000 series model (Topcon
Corporation, Tokyo, Japan) which showed outer
retinal layer atrophy along with pigmentation in the
macula and no macular edema bilaterally [Figure
3].
The patient had a genetic testing for her eye
condition at the closest genetic testing center
in 2012 on a specialist’s advice. The molecular
and genetic testing results were received in 2014,
and the reports showed that she carried a com-
pound heterogenous pair of alterations in the
CRB1gene that is associated with RP (type 12) and
LCA type-8 due to the mutation. The geneticist
reported that more appropriate designation is LCA-
8 as one of the alleles is a null allele which is
more frequently associated with LCA type-8. The
methodology used for genetic testing was a next-
generation massively parallel sequencing with a
panel of 105 genes associated with retinal dystro-
phy. The abnormal findings were then confirmed
through Sanger sequencing. The patient’s detailed
results for both CRB1genes having mutations
were CRB1c.498_506del9 p.(IIe 167_Gly169del)
and CRB1c.2688T>A p.(Cys896Ter). She was then
identified as harboring CRB1gene mutation caus-
ing LCA type-8 with retinitis pigmentosa spectrum
in both eyes.
Second Patient (Younger Sister)
A 53-year-old lady was examined in the eye clinic
at the NDDH in September 2015 as referred by
her GP as she had problems with her right eye
vision since a young age like her older sister. She
also underwent a genetic testing several months
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Figure 1. Right fundus picture of older sister showing bony spicule pigmentation and foveal atrophy.
Figure 2. Left fundus picture of older sister showing bony spicule pigmentation and foveal atrophy.
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Figure 3. Right OCT of older sister showing hypertrophy of RPE layer and thinning of outer retinal layers.
ago. She was initially diagnosed as having prob-
able age-related macular degeneration based on
clinical examination at the Moorfields Eye Hospital.
She also had an ERG (done with Observer-reviewer
system machine at the Moorfields Hospital, UK)
which was performed with gold foil recording elec-
trodes according to the international standards and
was found to be subnormal on the right side with
lower level responses. Rod-specific ERG-b wave
amplitudes were 145 µV on the right and 270 µV
on the left sides, respectively. Bright flash ERG “a”
and “b” wave amplitudes were 170 µV and 280 µV
in the right eye and 305 µV and 560 µV in the left
eye, respectively. She also had a pattern ERG P50
which was also found to be subnormal (0.6 µV) on
the right side being reported as a delayed pattern
ERG. The EOG (also done with Observer-reviewer
system machine at the Moorfields Hospital, UK)
was essentially normal for both eyes. The EOG light
rise was 185% in the right eye and 200% in the left
eye.
The patient complained of poor vision in her
right eye. On examination in the eye clinic, the best
corrected visual acuity was 6/36 in the right and 6/6
in the left eye. Anterior segment examination was
normal and unremarkable. IOPwas in normal range
on both sides. On dilated funduscopy, a central
macular atrophy with a mottled fundus appearance
on the right side and an eccentric atrophic patch
on the left side, just above the macular area,
sparing the macula, were observed which were
also visible in the fundus photos [Figures 4 and
5]. Optic discs were found to be normal on both
sides. An OCT scan was performed with Topcon
3D-OCT 2000 model which revealed RPE atrophy
in the right eye along with thinning of the outer
retinal layers [Figure 6] and a less marked foveal
sparing RPE atrophic patch in the left eye. The
genetic testing in her case was done through
Sanger sequencing, like her sister. Her genetic
testing results showed a compound heterozygous
genetic mutation of both CRB1genes which was
exactly similar to her older sister. Her detailed
results for both CRB1genes having mutations
are CRB1c.498_506del9 p.(IIe 167_Gly169del) and
CRB1c.2688T>A p.(Cys896Ter). Geneticist con-
firmed that the mutations were affecting both
alleles of the CRB1gene and since both of them
were nonsense mutations, they were securely
pathogenic and not carrier genes; this causes LCA-
8. Hence, she was considered to have a milder
phenotype of LCA type-8.
DISCUSSION
CRB1is a human homologue of the Drosophila
melanogaster gene crumbs (crb) and is localized in
the inner segment of mammalian photoreceptors
and the human fetal brain.[4] The CRB1gene is
located on chromosome 1q31.3 in humans and is
composed of 12 exons generating two different
transcripts of 1376 and 1406 amino acids. It plays
a crucial role in photoreceptor morphogenesis and
subsequent function. CRB1has been indicated to
be involved in mechanisms that control intracellular
communication and polarity as well as maintain
adherent junctions of epithelial cells.[5, 6]
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Figure 4. Right fundus picture of younger sister showing central macular atrophy with a mottled fundus appearance.
Figure 5. Left fundus picture of younger sister showing eccentric flat atrophic patch sparing the macula.
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Figure 6. Right eye OCT scan of younger sister showing thinning of outer retinal layers.
CRB1gene mutation is one of the most com-
mon genetic mutations found in the LCA patients.
According to some studies, about 7–10% of LCA
patients[7, 8] have CRB1genemutation as the under-
lying cause.
CRB1gene mutation is also responsible for a
characteristic form of autosomal recessive RP
which is known as RP12.[9] Unfortunately LCA-8 has
no treatment at present. Only one type of LCA that
is type-2 has been successfully treated using gene
therapy in 2008.[10, 11]
CRB1gene mutation results in many phenotypes.
In the studies conducted till date, there has been
no clear or defining genotype–phenotype relation-
ship established in CRB1 disease.[12] One meta-
analysis study suggested that different phenotypes
of patients with CRB1 gene mutations might be
due to additional modifying factors (genetic or/and
environmental) rather than a particular mutant
allele combination.[13]
Variations in the coding sequence of the
CRB1 gene mutation can cause disease, result-
ing in different phenotypes according to some
researchers.[14]
Li et al[15] have described the association of
CRB1 mutations with RP and LCA suggestive of
early onset RP being a spectrum from LCA to RP
and genes associated with early onset RP being
potentially good candidates for causing LCA and
vice versa.
CRB1 gene mutation in this case has resulted in
causing varying degrees of LCA-8 in both sisters
with a severe phenotype in the older sibling (LCA-8
with retinitis pigmentosa spectrum in both eyes)
and a milder phenotype causing LCA-8 with less
severe rod cone dystrophy in the younger one.
It is interesting to note that both sisters have
similar genotype and exactly same set of mutations
but they exhibit varying phenotypes. In summary,
mechanisms of CRB1 genetic mutation leading to
varying phenotypes are still not well understood.
Our case report is rare and interesting in the
fact that we are presenting a case, which to the
best of our knowledge, has not been reported
previously in siblings for such scenarios where
the exact same CRB1 genotypic mutation in two
sisters resulted in markedly different phenotypes.
We further concluded that the presence of different
phenotypes associated with identical genotypic
mutations in the same gene in siblings or in a family
must be considered especially when dealing with
retinal dystrophies.
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